{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:23:55Z","timestamp":1792290235919,"version":"4.4.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-438232"],"award-info":[{"award-number":["PJT-438232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-024-02831-w","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:46:12Z","timestamp":1732679172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Functional profiling of murine glioma models highlights targetable immune evasion phenotypes"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-0384","authenticated-orcid":false,"given":"Nicholas","family":"Mikolajewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Tatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-3865","authenticated-orcid":false,"given":"Adrian","family":"Granda Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassil","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Zador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuheli","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Aguilera-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-8586","authenticated-orcid":false,"given":"Jason","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2831_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13:767. https:\/\/doi.org\/10.1038\/s41467-022-28372-y","journal-title":"Nat Commun"},{"key":"2831_CR2","first-page":"2394","volume":"30","author":"JI Ausman","year":"1970","unstructured":"Ausman JI, Shapiro WR, Rall DP (1970) Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res 30:2394\u20132400","journal-title":"Cancer Res"},{"key":"2831_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnen\/63.2.170","volume":"63","author":"B Azzarelli","year":"2004","unstructured":"Azzarelli B, Miravalle L, Vidal R (2004) Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors. J Neuropathol Exp Neurol 63:170\u2013179. https:\/\/doi.org\/10.1093\/jnen\/63.2.170","journal-title":"J Neuropathol Exp Neurol"},{"key":"2831_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","volume":"576","author":"FP Barthel","year":"2019","unstructured":"Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112\u2013120. https:\/\/doi.org\/10.1038\/s41586-019-1775-1","journal-title":"Nature"},{"key":"2831_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neo.2014.03.006","volume":"16","author":"AD Berezovsky","year":"2014","unstructured":"Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW et al (2014) Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Neoplasia 16:193\u2013206. https:\/\/doi.org\/10.1016\/j.neo.2014.03.006","journal-title":"Neoplasia"},{"key":"2831_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41467-022-29469-0","volume":"13","author":"D Bernareggi","year":"2022","unstructured":"Bernareggi D, Xie Q, Prager BC, Yun J, Cruz LS, Pham TV et al (2022) CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nat Commun 13:1899. https:\/\/doi.org\/10.1038\/s41467-022-29469-0","journal-title":"Nat Commun"},{"key":"2831_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.cell.2012.10.053","volume":"151","author":"SF Boj","year":"2012","unstructured":"Boj SF, van Es JH, Huch M, Li VS, Jose A, Hatzis P et al (2012) Diabetes risk gene and Wnt effector Tcf7l2\/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151:1595\u20131607. https:\/\/doi.org\/10.1016\/j.cell.2012.10.053","journal-title":"Cell"},{"key":"2831_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1101\/gad.293027.116","volume":"31","author":"H Bulstrode","year":"2017","unstructured":"Bulstrode H, Johnstone E, Marques-Torrejon MA, Ferguson KM, Bressan RB, Blin C et al (2017) Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators. Genes Dev 31:757\u2013773. https:\/\/doi.org\/10.1101\/gad.293027.116","journal-title":"Genes Dev"},{"key":"2831_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ et al (2019) The single-cell transcriptional landscape of mammalian organogenesis. Nature 566:496\u2013502. https:\/\/doi.org\/10.1038\/s41586-019-0969-x","journal-title":"Nature"},{"key":"2831_CR10","doi-asserted-by":"publisher","first-page":"18922","DOI":"10.1074\/jbc.M702504200","volume":"282","author":"W Cao","year":"2007","unstructured":"Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L et al (2007) RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J Biol Chem 282:18922\u201318928. https:\/\/doi.org\/10.1074\/jbc.M702504200","journal-title":"J Biol Chem"},{"key":"2831_CR11","doi-asserted-by":"publisher","DOI":"10.3791\/59780","author":"K Chan","year":"2019","unstructured":"Chan K, Tong AHY, Brown KR, Mero P, Moffat J (2019) Pooled CRISPR-based genetic screens in mammalian cells. J Vis Exp. https:\/\/doi.org\/10.3791\/59780","journal-title":"J Vis Exp"},{"key":"2831_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1158\/0008-5472.CAN-19-1305","volume":"80","author":"A Chandra","year":"2020","unstructured":"Chandra A, Jahangiri A, Chen W, Nguyen AT, Yagnik G, Pereira MP et al (2020) Clonal ZEB1-driven mesenchymal transition promotes targetable oncologic antiangiogenic therapy resistance. Cancer Res 80:1498\u20131511. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1305","journal-title":"Cancer Res"},{"key":"2831_CR13","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.xpro.2020.100179","volume":"1","author":"CR Chokshi","year":"2020","unstructured":"Chokshi CR, Savage N, Venugopal C, Singh SK (2020) A patient-derived xenograft model of glioblastoma. STAR Protoc 1:100179. https:\/\/doi.org\/10.1016\/j.xpro.2020.100179","journal-title":"STAR Protoc"},{"key":"2831_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB et al (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25:477\u2013486. https:\/\/doi.org\/10.1038\/s41591-018-0337-7","journal-title":"Nat Med"},{"key":"2831_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06816-9","volume":"625","author":"A Cui","year":"2024","unstructured":"Cui A, Huang T, Li S, Ma A, Perez JL, Sander C et al (2024) Dictionary of immune responses to cytokines at single-cell resolution. Nature 625:377\u2013384. https:\/\/doi.org\/10.1038\/s41586-023-06816-9","journal-title":"Nature"},{"key":"2831_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann E, Henderson NC, Teichmann SA, Morgan MD, Marioni JC (2022) Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat Biotechnol 40:245\u2013253. https:\/\/doi.org\/10.1038\/s41587-021-01033-z","journal-title":"Nat Biotechnol"},{"key":"2831_CR17","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL (2021) cancer immune evasion through loss of MHC class I antigen presentation. Front Immunol 12:636568. https:\/\/doi.org\/10.3389\/fimmu.2021.636568","journal-title":"Front Immunol"},{"key":"2831_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41587-020-0465-8","volume":"38","author":"J Ding","year":"2020","unstructured":"Ding J, Adiconis X, Simmons SK, Kowalczyk MS, Hession CC, Marjanovic ND et al (2020) Systematic comparison of single-cell and single-nucleus RNA-sequencing methods. Nat Biotechnol 38:737\u2013746. https:\/\/doi.org\/10.1038\/s41587-020-0465-8","journal-title":"Nat Biotechnol"},{"key":"2831_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-019-0956-8","volume":"18","author":"S Duan","year":"2019","unstructured":"Duan S, Guo W, Xu Z, He Y, Liang C, Mo Y et al (2019) Natural killer group 2D receptor and its ligands in cancer immune escape. Mol Cancer 18:29. https:\/\/doi.org\/10.1186\/s12943-019-0956-8","journal-title":"Mol Cancer"},{"key":"2831_CR20","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","volume":"23","author":"J Dubrot","year":"2022","unstructured":"Dubrot J, Du PP, Lane-Reticker SK, Kessler EA, Muscato AJ, Mehta A et al (2022) In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer. Nat Immunol 23:1495\u20131506. https:\/\/doi.org\/10.1038\/s41590-022-01315-x","journal-title":"Nat Immunol"},{"key":"2831_CR21","doi-asserted-by":"publisher","first-page":"D1365","DOI":"10.1093\/nar\/gkaa882","volume":"49","author":"L Dwane","year":"2021","unstructured":"Dwane L, Behan FM, Goncalves E, Lightfoot H, Yang W, van der Meer D et al (2021) Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets. Nucleic Acids Res 49:D1365\u2013D1372. https:\/\/doi.org\/10.1093\/nar\/gkaa882","journal-title":"Nucleic Acids Res"},{"key":"2831_CR22","doi-asserted-by":"publisher","first-page":"e0205501","DOI":"10.1371\/journal.pone.0205501","volume":"13","author":"D Fortuna","year":"2018","unstructured":"Fortuna D, Hooper DC, Roberts AL, Harshyne LA, Nagurney M, Curtis MT (2018) Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders. PLoS ONE 13:e0205501. https:\/\/doi.org\/10.1371\/journal.pone.0205501","journal-title":"PLoS ONE"},{"key":"2831_CR23","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41467-022-29412-3","volume":"13","author":"N Frey","year":"2022","unstructured":"Frey N, Tortola L, Egli D, Janjuha S, Rothgangl T, Marquart KF et al (2022) Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing. Nat Commun 13:1804. https:\/\/doi.org\/10.1038\/s41467-022-29412-3","journal-title":"Nat Commun"},{"key":"2831_CR24","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1523\/JNEUROSCI.0160-09.2009","volume":"29","author":"H Fu","year":"2009","unstructured":"Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R et al (2009) A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29:11399\u201311408. https:\/\/doi.org\/10.1523\/JNEUROSCI.0160-09.2009","journal-title":"J Neurosci"},{"key":"2831_CR25","doi-asserted-by":"publisher","first-page":"17072","DOI":"10.1101\/2023.10.26.564166","volume":"8","author":"L Garc\u00eda-Vicente","year":"2023","unstructured":"Garc\u00eda-Vicente L, Borja M, Tran V, \u00c1lvarez-V\u00e1zquez A, Flores-Hern\u00e1ndez R, Granados A et al (2023) Single-nucleus RNA sequencing provides insights into the GL261-GSC syngeneic mouse model of glioblastoma. BioRxiv 8:17072. https:\/\/doi.org\/10.1101\/2023.10.26.564166","journal-title":"BioRxiv"},{"key":"2831_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.19.473368","author":"A Gavish","year":"2021","unstructured":"Gavish A, Tyler M, Simkin D, Kovarsky D, Gonzalez Castro LN, Halder D et al (2021) The transcriptional hallmarks of intra-tumor heterogeneity across a thousand tumors. BioRxiv. https:\/\/doi.org\/10.1101\/2021.12.19.473368","journal-title":"BioRxiv"},{"key":"2831_CR27","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/nn.3790","volume":"17","author":"SM Glasgow","year":"2014","unstructured":"Glasgow SM, Zhu W, Stolt CC, Huang TW, Chen F, LoTurco JJ et al (2014) Mutual antagonism between Sox10 and NFIA regulates diversification of glial lineages and glioma subtypes. Nat Neurosci 17:1322\u20131329. https:\/\/doi.org\/10.1038\/nn.3790","journal-title":"Nat Neurosci"},{"key":"2831_CR28","doi-asserted-by":"publisher","first-page":"31637","DOI":"10.18632\/oncotarget.25827","volume":"9","author":"V Gouaze-Andersson","year":"2018","unstructured":"Gouaze-Andersson V, Gherardi MJ, Lemarie A, Gilhodes J, Lubrano V, Arnauduc F et al (2018) FGFR1\/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker. Oncotarget 9:31637\u201331649. https:\/\/doi.org\/10.18632\/oncotarget.25827","journal-title":"Oncotarget"},{"key":"2831_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R (2019) Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol 20:296. https:\/\/doi.org\/10.1186\/s13059-019-1874-1","journal-title":"Genome Biol"},{"key":"2831_CR30","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, Cho JW, Lee S, Yun A, Kim H, Bae D et al (2018) TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res 46:D380\u2013D386. https:\/\/doi.org\/10.1093\/nar\/gkx1013","journal-title":"Nucleic Acids Res"},{"issue":"3573\u20133587","key":"2831_CR31","doi-asserted-by":"publisher","first-page":"e3529","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A et al (2021) Integrated analysis of multimodal single-cell data. Cell 184(3573\u20133587):e3529. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048","journal-title":"Cell"},{"key":"2831_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12859-016-1015-8","volume":"17","author":"T Hart","year":"2016","unstructured":"Hart T, Moffat J (2016) BAGEL: a computational framework for identifying essential genes from pooled library screens. BMC Bioinform 17:164. https:\/\/doi.org\/10.1186\/s12859-016-1015-8","journal-title":"BMC Bioinform"},{"key":"2831_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","volume":"18","author":"C Horbinski","year":"2022","unstructured":"Horbinski C, Berger T, Packer RJ, Wen PY (2022) Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. Nat Rev Neurol 18:515\u2013529. https:\/\/doi.org\/10.1038\/s41582-022-00679-w","journal-title":"Nat Rev Neurol"},{"key":"2831_CR34","doi-asserted-by":"publisher","first-page":"D33","DOI":"10.1093\/nar\/gky822","volume":"47","author":"H Hu","year":"2019","unstructured":"Hu H, Miao YR, Jia LH, Yu QY, Zhang Q, Guo AY (2019) AnimalTFDB 3.0: a comprehensive resource for annotation and prediction of animal transcription factors. Nucleic Acids Res 47:D33\u2013D38. https:\/\/doi.org\/10.1093\/nar\/gky822","journal-title":"Nucleic Acids Res"},{"key":"2831_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030690","author":"NR Hum","year":"2020","unstructured":"Hum NR, Sebastian A, Gilmore SF, He W, Martin KA, Hinckley A et al (2020) Comparative molecular analysis of cancer behavior cultured in vitro, in vivo, and ex vivo. Cancers. https:\/\/doi.org\/10.3390\/cancers12030690","journal-title":"Cancers"},{"key":"2831_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091139","author":"C Iacobini","year":"2021","unstructured":"Iacobini C, Vitale M, Pugliese G, Menini S (2021) Normalizing HIF-1alpha signaling improves cellular glucose metabolism and blocks the pathological pathways of hyperglycemic damage. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9091139","journal-title":"Biomedicines"},{"key":"2831_CR37","doi-asserted-by":"publisher","first-page":"1297932","DOI":"10.3389\/fimmu.2023.1297932","volume":"14","author":"JB Iorgulescu","year":"2023","unstructured":"Iorgulescu JB, Ruthen N, Ahn R, Panagioti E, Gokhale PC, Neagu M et al (2023) Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Front Immunol 14:1297932. https:\/\/doi.org\/10.3389\/fimmu.2023.1297932","journal-title":"Front Immunol"},{"key":"2831_CR38","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"2831_CR39","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.21037\/tcr-20-492","volume":"9","author":"YW Jiang","year":"2020","unstructured":"Jiang YW, Wang R, Zhuang YD, Chen CM (2020) Identification and validation of potential novel prognostic biomarkers for patients with glioma based on a gene co-expression network. Transl Cancer Res 9:6444\u20136454. https:\/\/doi.org\/10.21037\/tcr-20-492","journal-title":"Transl Cancer Res"},{"key":"2831_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1158\/2326-6066.CIR-16-0156","volume":"4","author":"TM Johanns","year":"2016","unstructured":"Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D et al (2016) Endogenous neoantigen-specific CD8 T cells identified in two glioblastoma models using a cancer immunogenomics approach. Cancer Immunol Res 4:1007\u20131015. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0156","journal-title":"Cancer Immunol Res"},{"key":"2831_CR41","doi-asserted-by":"publisher","first-page":"e1443","DOI":"10.1038\/cddis.2014.395","volume":"5","author":"JV Joseph","year":"2014","unstructured":"Joseph JV, Conroy S, Tomar T, Eggens-Meijer E, Bhat K, Copray S et al (2014) TGF-beta is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis 5:e1443. https:\/\/doi.org\/10.1038\/cddis.2014.395","journal-title":"Cell Death Dis"},{"key":"2831_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13578-022-00887-3","volume":"12","author":"C Jubelin","year":"2022","unstructured":"Jubelin C, Munoz-Garcia J, Griscom L, Cochonneau D, Ollivier E, Heymann MF et al (2022) Three-dimensional in vitro culture models in oncology research. Cell Biosci 12:155. https:\/\/doi.org\/10.1186\/s13578-022-00887-3","journal-title":"Cell Biosci"},{"key":"2831_CR43","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-021-03879-4","volume":"597","author":"RA Kamber","year":"2021","unstructured":"Kamber RA, Nishiga Y, Morton B, Banuelos AM, Barkal AA, Vences-Catalan F et al (2021) Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis. Nature 597:549\u2013554. https:\/\/doi.org\/10.1038\/s41586-021-03879-4","journal-title":"Nature"},{"key":"2831_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar3451","author":"CJ Kearney","year":"2018","unstructured":"Kearney CJ, Vervoort SJ, Hogg SJ, Ramsbottom KM, Freeman AJ, Lalaoui N et al (2018) Tumor immune evasion arises through loss of TNF sensitivity. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aar3451","journal-title":"Sci Immunol"},{"key":"2831_CR45","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1038\/s41467-020-17704-5","volume":"11","author":"JK Khalsa","year":"2020","unstructured":"Khalsa JK, Cheng N, Keegan J, Chaudry A, Driver J, Bi WL et al (2020) Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nat Commun 11:3912. https:\/\/doi.org\/10.1038\/s41467-020-17704-5","journal-title":"Nat Commun"},{"key":"2831_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005293","author":"SM Khan","year":"2022","unstructured":"Khan SM, Desai R, Coxon A, Livingstone A, Dunn GP, Petti A et al (2022) Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-005293","journal-title":"J Immunother Cancer"},{"key":"2831_CR47","unstructured":"Kijima N, Kanemura Y (2017) Mouse models of glioblastoma. In: De Vleeschouwer S (ed) Glioblastoma, City"},{"key":"2831_CR48","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3892\/ijo.2015.2930","volume":"46","author":"SW Kim","year":"2015","unstructured":"Kim SW, Kim SJ, Langley RR, Fidler IJ (2015) Modulation of the cancer cell transcriptome by culture media formulations and cell density. Int J Oncol 46:2067\u20132075. https:\/\/doi.org\/10.3892\/ijo.2015.2930","journal-title":"Int J Oncol"},{"key":"2831_CR49","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker GS, Greenwald AC, Tal R, Orlova Z, Cuoco MS, McFarland JM et al (2020) Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet 52:1208\u20131218. https:\/\/doi.org\/10.1038\/s41588-020-00726-6","journal-title":"Nat Genet"},{"issue":"149\u2013165","key":"2831_CR50","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.cell.2023.11.032","volume":"187","author":"D Kirschenbaum","year":"2024","unstructured":"Kirschenbaum D, Xie K, Ingelfinger F, Katzenelenbogen Y, Abadie K, Look T et al (2024) Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma. Cell 187(149\u2013165):e123. https:\/\/doi.org\/10.1016\/j.cell.2023.11.032","journal-title":"Cell"},{"key":"2831_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-021-03775-x","volume":"596","author":"G La Manno","year":"2021","unstructured":"La Manno G, Siletti K, Furlan A, Gyllborg D, Vinsland E, Mossi Albiach A et al (2021) Molecular architecture of the developing mouse brain. Nature 596:92\u201396. https:\/\/doi.org\/10.1038\/s41586-021-03775-x","journal-title":"Nature"},{"key":"2831_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","volume":"586","author":"KA Lawson","year":"2020","unstructured":"Lawson KA, Sousa CM, Zhang X, Kim E, Akthar R, Caumanns JJ et al (2020) Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. Nature 586:120\u2013126. https:\/\/doi.org\/10.1038\/s41586-020-2746-2","journal-title":"Nature"},{"key":"2831_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/neuonc\/now233","volume":"19","author":"J Lee","year":"2017","unstructured":"Lee J, Hoxha E, Song HR (2017) A novel NFIA-NFkappaB feed-forward loop contributes to glioblastoma cell survival. Neuro Oncol 19:524\u2013534. https:\/\/doi.org\/10.1093\/neuonc\/now233","journal-title":"Neuro Oncol"},{"key":"2831_CR54","doi-asserted-by":"publisher","first-page":"e0137703","DOI":"10.1371\/journal.pone.0137703","volume":"10","author":"Y Lee","year":"2015","unstructured":"Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J et al (2015) FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2. PLoS One 10:e0137703. https:\/\/doi.org\/10.1371\/journal.pone.0137703","journal-title":"PLoS One"},{"key":"2831_CR55","doi-asserted-by":"publisher","first-page":"e10210","DOI":"10.1371\/journal.pone.0010210","volume":"5","author":"B Lin","year":"2010","unstructured":"Lin B, Madan A, Yoon JG, Fang X, Yan X, Kim TK et al (2010) Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS One 5:e10210. https:\/\/doi.org\/10.1371\/journal.pone.0010210","journal-title":"PLoS One"},{"key":"2831_CR56","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1038\/s41467-020-16904-3","volume":"11","author":"B Liu","year":"2020","unstructured":"Liu B, Li C, Li Z, Wang D, Ren X, Zhang Z (2020) An entropy-based metric for assessing the purity of single cell populations. Nat Commun 11:3155. https:\/\/doi.org\/10.1038\/s41467-020-16904-3","journal-title":"Nat Commun"},{"key":"2831_CR57","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/neuonc\/noaa050","volume":"22","author":"CJ Liu","year":"2020","unstructured":"Liu CJ, Schaettler M, Blaha DT, Bowman-Kirigin JA, Kobayashi DK, Livingstone AJ et al (2020) Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro Oncol 22:1276\u20131288. https:\/\/doi.org\/10.1093\/neuonc\/noaa050","journal-title":"Neuro Oncol"},{"key":"2831_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"2831_CR59","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2831_CR60","doi-asserted-by":"publisher","first-page":"978921","DOI":"10.3389\/fonc.2022.978921","volume":"12","author":"H Lu","year":"2022","unstructured":"Lu H, Zheng LY, Wu LY, Chen J, Xu N, Mi SC (2022) The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma. Front Oncol 12:978921. https:\/\/doi.org\/10.3389\/fonc.2022.978921","journal-title":"Front Oncol"},{"key":"2831_CR61","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3892\/etm.2020.8426","volume":"19","author":"C Luo","year":"2020","unstructured":"Luo C, Quan Z, Zhong B, Zhang M, Zhou B, Wang S et al (2020) lncRNA XIST promotes glioma proliferation and metastasis through miR-133a\/SOX4. Exp Ther Med 19:1641\u20131648. https:\/\/doi.org\/10.3892\/etm.2020.8426","journal-title":"Exp Ther Med"},{"key":"2831_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/0008-5472.CAN-18-1304","volume":"79","author":"L Ma","year":"2019","unstructured":"Ma L, Lin K, Chang G, Chen Y, Yue C, Guo Q et al (2019) Aberrant activation of beta-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2. Cancer Res 79:72\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1304","journal-title":"Cancer Res"},{"issue":"971\u2013986","key":"2831_CR63","doi-asserted-by":"publisher","first-page":"e979","DOI":"10.1016\/j.celrep.2019.03.047","volume":"27","author":"G MacLeod","year":"2019","unstructured":"MacLeod G, Bozek DA, Rajakulendran N, Monteiro V, Ahmadi M, Steinhart Z et al (2019) Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells. Cell Rep 27(971\u2013986):e979. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.047","journal-title":"Cell Rep"},{"key":"2831_CR64","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41551-019-0454-8","volume":"3","author":"B Mair","year":"2019","unstructured":"Mair B, Aldridge PM, Atwal RS, Philpott D, Zhang M, Masud SN et al (2019) High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting. Nat Biomed Eng 3:796\u2013805. https:\/\/doi.org\/10.1038\/s41551-019-0454-8","journal-title":"Nat Biomed Eng"},{"key":"2831_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC et al (2017) In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547:413\u2013418. https:\/\/doi.org\/10.1038\/nature23270","journal-title":"Nature"},{"key":"2831_CR66","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1158\/1078-0432.CCR-08-0213","volume":"14","author":"J Marsh","year":"2008","unstructured":"Marsh J, Mukherjee P, Seyfried TN (2008) Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue\/tuberous sclerosis complex 2-deficient mouse astrocytoma. Clin Cancer Res 14:7751\u20137762. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0213","journal-title":"Clin Cancer Res"},{"key":"2831_CR67","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41596-022-00752-0","volume":"18","author":"BK Martin","year":"2023","unstructured":"Martin BK, Qiu C, Nichols E, Phung M, Green-Gladden R, Srivatsan S et al (2023) Optimized single-nucleus transcriptional profiling by combinatorial indexing. Nat Protoc 18:188\u2013207. https:\/\/doi.org\/10.1038\/s41596-022-00752-0","journal-title":"Nat Protoc"},{"key":"2831_CR68","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.14670\/HH-22.1309","volume":"22","author":"R Martinez-Murillo","year":"2007","unstructured":"Martinez-Murillo R, Martinez A (2007) Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells. Histol Histopathol 22:1309\u20131326. https:\/\/doi.org\/10.14670\/HH-22.1309","journal-title":"Histol Histopathol"},{"issue":"446\u2013463","key":"2831_CR69","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1016\/j.cell.2023.12.013","volume":"187","author":"R Mathur","year":"2024","unstructured":"Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C et al (2024) Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell 187(446\u2013463):e416. https:\/\/doi.org\/10.1016\/j.cell.2023.12.013","journal-title":"Cell"},{"key":"2831_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","volume":"20","author":"T McGranahan","year":"2019","unstructured":"McGranahan T, Therkelsen KE, Ahmad S, Nagpal S (2019) Current state of immunotherapy for treatment of glioblastoma. Curr Treat Options Oncol 20:24. https:\/\/doi.org\/10.1007\/s11864-019-0619-4","journal-title":"Curr Treat Options Oncol"},{"key":"2831_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-022-01990-y","volume":"17","author":"KJ McKelvey","year":"2022","unstructured":"McKelvey KJ, Hudson AL, Donaghy H, Stoner SP, Wheeler HR, Diakos CI et al (2022) Differential effects of radiation fractionation regimens on glioblastoma. Radiat Oncol 17:17. https:\/\/doi.org\/10.1186\/s13014-022-01990-y","journal-title":"Radiat Oncol"},{"key":"2831_CR72","doi-asserted-by":"publisher","first-page":"e0226444","DOI":"10.1371\/journal.pone.0226444","volume":"15","author":"KJ McKelvey","year":"2020","unstructured":"McKelvey KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, Attrill GH, Long GV et al (2020) Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model. PLoS ONE 15:e0226444. https:\/\/doi.org\/10.1371\/journal.pone.0226444","journal-title":"PLoS ONE"},{"key":"2831_CR73","doi-asserted-by":"publisher","first-page":"633210","DOI":"10.3389\/fonc.2021.633210","volume":"11","author":"KJ McKelvey","year":"2021","unstructured":"McKelvey KJ, Wilson EB, Short S, Melcher AA, Biggs M, Diakos CI et al (2021) Glycolysis and fatty acid oxidation inhibition improves survival in glioblastoma. Front Oncol 11:633210. https:\/\/doi.org\/10.3389\/fonc.2021.633210","journal-title":"Front Oncol"},{"key":"2831_CR74","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR (2014) Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol 87:20130676. https:\/\/doi.org\/10.1259\/bjr.20130676","journal-title":"Br J Radiol"},{"key":"2831_CR75","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc3243","author":"BL Menasche","year":"2020","unstructured":"Menasche BL, Davis EM, Wang S, Ouyang Y, Li S, Yu H et al (2020) PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abc3243","journal-title":"Sci Adv"},{"key":"2831_CR76","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/neuonc\/nou161","volume":"17","author":"AM Mikheev","year":"2015","unstructured":"Mikheev AM, Mikheeva SA, Trister AD, Tokita MJ, Emerson SN, Parada CA et al (2015) Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. Neuro Oncol 17:372\u2013382. https:\/\/doi.org\/10.1093\/neuonc\/nou161","journal-title":"Neuro Oncol"},{"key":"2831_CR77","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/1878-0261.13496","volume":"18","author":"SA Mikheeva","year":"2024","unstructured":"Mikheeva SA, Funk CC, Horner PJ, Rostomily RC, Mikheev AM (2024) Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth. Mol Oncol 18:517\u2013527. https:\/\/doi.org\/10.1002\/1878-0261.13496","journal-title":"Mol Oncol"},{"key":"2831_CR78","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s42003-022-04093-2","volume":"5","author":"N Mikolajewicz","year":"2022","unstructured":"Mikolajewicz N, Gacesa R, Aguilera-Uribe M, Brown KR, Moffat J, Han H (2022) Multi-level cellular and functional annotation of single-cell transcriptomes using scPipeline. Communications Biology 5:1142","journal-title":"Communications Biology"},{"key":"2831_CR79","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.1818210116","volume":"116","author":"A Miranda","year":"2019","unstructured":"Miranda A, Hamilton PT, Zhang AW, Pattnaik S, Becht E, Mezheyeuski A et al (2019) Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc Natl Acad Sci U S A 116:9020\u20139029. https:\/\/doi.org\/10.1073\/pnas.1818210116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2831_CR80","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2990.2004.00612.x","volume":"31","author":"K Mokhtari","year":"2005","unstructured":"Mokhtari K, Paris S, Aguirre-Cruz L, Privat N, Criniere E, Marie Y et al (2005) Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol 31:62\u201369. https:\/\/doi.org\/10.1111\/j.1365-2990.2004.00612.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2831_CR81","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-04-0308","volume":"10","author":"P Mukherjee","year":"2004","unstructured":"Mukherjee P, Abate LE, Seyfried TN (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10:5622\u20135629. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0308","journal-title":"Clin Cancer Res"},{"issue":"835\u2013849","key":"2831_CR82","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178(835\u2013849):e821. https:\/\/doi.org\/10.1016\/j.cell.2019.06.024","journal-title":"Cell"},{"key":"2831_CR83","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41589-022-01093-5","volume":"18","author":"W Ngo","year":"2022","unstructured":"Ngo W, Wu JLY, Lin ZP, Zhang Y, Bussin B, Granda Farias A et al (2022) Identifying cell receptors for the nanoparticle protein corona using genome screens. Nat Chem Biol 18:1023\u20131031. https:\/\/doi.org\/10.1038\/s41589-022-01093-5","journal-title":"Nat Chem Biol"},{"key":"2831_CR84","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-021-03822-7","volume":"154","author":"B Noffsinger","year":"2021","unstructured":"Noffsinger B, Witter A, Sheybani N, Xiao A, Manigat L, Zhong Q et al (2021) Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner. J Neurooncol 154:145\u2013157. https:\/\/doi.org\/10.1007\/s11060-021-03822-7","journal-title":"J Neurooncol"},{"key":"2831_CR85","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41467-021-21407-w","volume":"12","author":"N Ochocka","year":"2021","unstructured":"Ochocka N, Segit P, Walentynowicz KA, Wojnicki K, Cyranowski S, Swatler J et al (2021) Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages. Nat Commun 12:1151. https:\/\/doi.org\/10.1038\/s41467-021-21407-w","journal-title":"Nat Commun"},{"key":"2831_CR86","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/jnen\/62.10.1052","volume":"62","author":"A Ohnishi","year":"2003","unstructured":"Ohnishi A, Sawa H, Tsuda M, Sawamura Y, Itoh T, Iwasaki Y et al (2003) Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 62:1052\u20131059. https:\/\/doi.org\/10.1093\/jnen\/62.10.1052","journal-title":"J Neuropathol Exp Neurol"},{"key":"2831_CR87","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-021-21898-7","volume":"12","author":"C Pacini","year":"2021","unstructured":"Pacini C, Dempster JM, Boyle I, Goncalves E, Najgebauer H, Karakoc E et al (2021) Integrated cross-study datasets of genetic dependencies in cancer. Nat Commun 12:1661. https:\/\/doi.org\/10.1038\/s41467-021-21898-7","journal-title":"Nat Commun"},{"key":"2831_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072033","author":"Y Pang","year":"2023","unstructured":"Pang Y, Zhou S, Zumbo P, Betel D, Cisse B (2023) TCF12 deficiency impairs the proliferation of glioblastoma tumor cells and improves survival. Cancers. https:\/\/doi.org\/10.3390\/cancers15072033","journal-title":"Cancers"},{"key":"2831_CR89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40478-014-0180-0","volume":"3","author":"S Pellegatta","year":"2015","unstructured":"Pellegatta S, Valletta L, Corbetta C, Patane M, Zucca I, Riccardi Sirtori F et al (2015) Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma. Acta Neuropathol Commun 3:4. https:\/\/doi.org\/10.1186\/s40478-014-0180-0","journal-title":"Acta Neuropathol Commun"},{"key":"2831_CR90","doi-asserted-by":"publisher","first-page":"111420","DOI":"10.1016\/j.celrep.2022.111420","volume":"40","author":"MA Qazi","year":"2022","unstructured":"Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H et al (2022) Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Cell Rep 40:111420. https:\/\/doi.org\/10.1016\/j.celrep.2022.111420","journal-title":"Cell Rep"},{"key":"2831_CR91","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.3390\/curroncol30060428","volume":"30","author":"AL Ren","year":"2023","unstructured":"Ren AL, Wu JY, Lee SY, Lim M (2023) Translational models in glioma immunotherapy research. Curr Oncol 30:5704\u20135718. https:\/\/doi.org\/10.3390\/curroncol30060428","journal-title":"Curr Oncol"},{"key":"2831_CR92","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s43018-020-00154-9","volume":"2","author":"LM Richards","year":"2021","unstructured":"Richards LM, Whitley OKN, MacLeod G, Cavalli FMG, Coutinho FJ, Jaramillo JE et al (2021) Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat Cancer 2:157\u2013173. https:\/\/doi.org\/10.1038\/s43018-020-00154-9","journal-title":"Nat Cancer"},{"key":"2831_CR93","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-003-0809-8","volume":"107","author":"MJ Riemenschneider","year":"2004","unstructured":"Riemenschneider MJ, Koy TH, Reifenberger G (2004) Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas. Acta Neuropathol 107:277\u2013282. https:\/\/doi.org\/10.1007\/s00401-003-0809-8","journal-title":"Acta Neuropathol"},{"key":"2831_CR94","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"2831_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092750","author":"A Rogalska","year":"2018","unstructured":"Rogalska A, Forma E, Brys M, Sliwinska A, Marczak A (2018) Hyperglycemia-associated dysregulation of O-GlcNAcylation and HIF1A reduces anticancer action of metformin in ovarian cancer cells (SKOV-3). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19092750","journal-title":"Int J Mol Sci"},{"key":"2831_CR96","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1365-2990.2007.00881.x","volume":"33","author":"B Schlierf","year":"2007","unstructured":"Schlierf B, Friedrich RP, Roerig P, Felsberg J, Reifenberger G, Wegner M (2007) Expression of SoxE and SoxD genes in human gliomas. Neuropathol Appl Neurobiol 33:621\u2013630. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00881.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2831_CR97","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1158\/ajc.1939.364","volume":"37","author":"AM Seligman","year":"1939","unstructured":"Seligman AM, Shear MJ, Alexander L (1939) Studies in carcinogenesis: VIII. Experimental Production of brain tumors in mice with methylcholanthrene1. Am J Cancer 37:364\u2013395. https:\/\/doi.org\/10.1158\/ajc.1939.364","journal-title":"Am J Cancer"},{"key":"2831_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092070","author":"B Sese","year":"2022","unstructured":"Sese B, Iniguez-Munoz S, Ensenyat-Mendez M, Llinas-Arias P, Ramis G, Orozco JIJ et al (2022) Glioblastoma embryonic-like stem cells exhibit immune-evasive phenotype. Cancers. https:\/\/doi.org\/10.3390\/cancers14092070","journal-title":"Cancers"},{"key":"2831_CR99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF03159989","volume":"17","author":"TN Seyfried","year":"1992","unstructured":"Seyfried TN, el-Abbadi M, Roy ML (1992) Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol 17:147\u2013167. https:\/\/doi.org\/10.1007\/BF03159989","journal-title":"Mol Chem Neuropathol"},{"key":"2831_CR100","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41588-021-00889-w","volume":"53","author":"M Sheffer","year":"2021","unstructured":"Sheffer M, Lowry E, Beelen N, Borah M, Amara SN, Mader CC et al (2021) Genome-scale screens identify factors regulating tumor cell responses to natural killer cells. Nat Genet 53:1196\u20131206. https:\/\/doi.org\/10.1038\/s41588-021-00889-w","journal-title":"Nat Genet"},{"key":"2831_CR101","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.drudis.2021.03.020","volume":"26","author":"KW Siah","year":"2021","unstructured":"Siah KW, Xu Q, Tanner K, Futer O, Frishkopf JJ, Lo AW (2021) Accelerating glioblastoma therapeutics via venture philanthropy. Drug Discov Today 26:1744\u20131749. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.020","journal-title":"Drug Discov Today"},{"key":"2831_CR102","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/s41591-023-02464-8","volume":"29","author":"K Singh","year":"2023","unstructured":"Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N et al (2023) Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nat Med 29:2402\u20132405. https:\/\/doi.org\/10.1038\/s41591-023-02464-8","journal-title":"Nat Med"},{"key":"2831_CR103","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I et al (2020) A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med 26:792\u2013802. https:\/\/doi.org\/10.1038\/s41591-020-0844-1","journal-title":"Nat Med"},{"key":"2831_CR104","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jcma.2016.03.010","volume":"79","author":"WS Song","year":"2016","unstructured":"Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW et al (2016) Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc 79:538\u2013545. https:\/\/doi.org\/10.1016\/j.jcma.2016.03.010","journal-title":"J Chin Med Assoc"},{"key":"2831_CR105","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-18-0545","volume":"78","author":"L Spel","year":"2018","unstructured":"Spel L, Nieuwenhuis J, Haarsma R, Stickel E, Bleijerveld OB, Altelaar M et al (2018) Nedd4-binding protein 1 and TNFAIP3-interacting protein 1 control MHC-1 display in neuroblastoma. Cancer Res 78:6621\u20136631. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0545","journal-title":"Cancer Res"},{"issue":"1888\u20131902","key":"2831_CR106","doi-asserted-by":"publisher","first-page":"e1821","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd et al (2019) Comprehensive integration of single-cell data. Cell 177(1888\u20131902):e1821. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","journal-title":"Cell"},{"key":"2831_CR107","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1349-7006.2006.00208.x","volume":"97","author":"T Szatmari","year":"2006","unstructured":"Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi EJ, Hamada H et al (2006) Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97:546\u2013553. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00208.x","journal-title":"Cancer Sci"},{"key":"2831_CR108","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.diabres.2013.12.021","volume":"104","author":"L Tang","year":"2014","unstructured":"Tang L, Li H, Gou R, Cheng G, Guo Y, Fang Y et al (2014) Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells. Diabetes Res Clin Pract 104:176\u2013182. https:\/\/doi.org\/10.1016\/j.diabres.2013.12.021","journal-title":"Diabetes Res Clin Pract"},{"key":"2831_CR109","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02482186","volume":"21","author":"R Ueda","year":"2004","unstructured":"Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M (2004) Immunohistochemical analysis of SOX6 expression in human brain tumors. Brain Tumor Pathol 21:117\u2013120. https:\/\/doi.org\/10.1007\/BF02482186","journal-title":"Brain Tumor Pathol"},{"issue":"2184\u20132199","key":"2831_CR110","doi-asserted-by":"publisher","first-page":"e2116","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P et al (2022) Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185(2184\u20132199):e2116. https:\/\/doi.org\/10.1016\/j.cell.2022.04.038","journal-title":"Cell"},{"key":"2831_CR111","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"},{"key":"2831_CR112","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","volume":"20","author":"DA Wainwright","year":"2014","unstructured":"Wainwright DA, Chang AL, Dey M, Balyasnikova IV, Kim CK, Tobias A et al (2014) Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res 20:5290\u20135301. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0514","journal-title":"Clin Cancer Res"},{"key":"2831_CR113","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, Jung J, Babikir H, Shamardani K, Jain S, Feng X et al (2022) A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer 3:1534\u20131552. https:\/\/doi.org\/10.1038\/s43018-022-00475-x","journal-title":"Nat Cancer"},{"key":"2831_CR114","doi-asserted-by":"publisher","DOI":"10.1242\/dev.196022","author":"MT Wittmann","year":"2021","unstructured":"Wittmann MT, Katada S, Sock E, Kirchner P, Ekici AB, Wegner M et al (2021) scRNA sequencing uncovers a TCF4-dependent transcription factor network regulating commissure development in mouse. Development. https:\/\/doi.org\/10.1242\/dev.196022","journal-title":"Development"},{"key":"2831_CR115","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1002\/cam4.3186","volume":"9","author":"J Wu","year":"2020","unstructured":"Wu J, Li R, Li L, Gu Y, Zhan H, Zhou C et al (2020) MYC-activated lncRNA HNF1A-AS1 overexpression facilitates glioma progression via cooperating with miR-32-5p\/SOX4 axis. Cancer Med 9:6387\u20136398. https:\/\/doi.org\/10.1002\/cam4.3186","journal-title":"Cancer Med"},{"key":"2831_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228775","author":"S Wu","year":"2020","unstructured":"Wu S, Calero-Perez P, Arus C, Candiota AP (2020) Anti-PD-1 immunotherapy in preclinical GL261 glioblastoma: influence of therapeutic parameters and non-invasive response biomarker assessment with MRSI-based approaches. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228775","journal-title":"Int J Mol Sci"},{"key":"2831_CR117","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","volume":"21","author":"H Xia","year":"2021","unstructured":"Xia H, Green DR, Zou W (2021) Autophagy in tumour immunity and therapy. Nat Rev Cancer 21:281\u2013297","journal-title":"Nat Rev Cancer"},{"key":"2831_CR118","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1093\/nar\/gkz381","volume":"47","author":"J Yang","year":"2019","unstructured":"Yang J, Horton JR, Li J, Huang Y, Zhang X, Blumenthal RM et al (2019) Structural basis for preferential binding of human TCF4 to DNA containing 5-carboxylcytosine. Nucleic Acids Res 47:8375\u20138387. https:\/\/doi.org\/10.1093\/nar\/gkz381","journal-title":"Nucleic Acids Res"},{"key":"2831_CR119","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nat Commun"},{"key":"2831_CR120","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/nsr\/nwaa099","volume":"7","author":"K Yu","year":"2020","unstructured":"Yu K, Hu Y, Wu F, Guo Q, Qian Z, Hu W et al (2020) Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies. Natl Sci Rev 7:1306\u20131318. https:\/\/doi.org\/10.1093\/nsr\/nwaa099","journal-title":"Natl Sci Rev"},{"key":"2831_CR121","doi-asserted-by":"publisher","first-page":"116917","DOI":"10.1016\/j.lfs.2019.116917","volume":"236","author":"X Yu","year":"2019","unstructured":"Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R et al (2019) Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor kappaB pathway. Life Sci 236:116917. https:\/\/doi.org\/10.1016\/j.lfs.2019.116917","journal-title":"Life Sci"},{"key":"2831_CR122","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/labinvest.3780088","volume":"80","author":"D Zagzag","year":"2000","unstructured":"Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ et al (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80:837\u2013849. https:\/\/doi.org\/10.1038\/labinvest.3780088","journal-title":"Lab Invest"},{"issue":"999\u20131014","key":"2831_CR123","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel A, Hochgerner H, Lonnerberg P, Johnsson A, Memic F, van der Zwan J et al (2018) Molecular architecture of the mouse nervous system. Cell 174(999\u20131014):e1022. https:\/\/doi.org\/10.1016\/j.cell.2018.06.021","journal-title":"Cell"},{"key":"2831_CR124","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.canlet.2014.11.003","volume":"356","author":"J Zhang","year":"2015","unstructured":"Zhang J, Chen L, Han L, Shi Z, Zhang J, Pu P et al (2015) EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Lett 356:929\u2013936. https:\/\/doi.org\/10.1016\/j.canlet.2014.11.003","journal-title":"Cancer Lett"},{"key":"2831_CR125","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","volume":"25","author":"J Zhao","year":"2019","unstructured":"Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T et al (2019) Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat Med 25:462\u2013469. https:\/\/doi.org\/10.1038\/s41591-019-0349-y","journal-title":"Nat Med"},{"key":"2831_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y et al (2021) Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genomics Proteomics Bioinform 19:1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005","journal-title":"Genomics Proteomics Bioinform"},{"key":"2831_CR127","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2147\/NDT.S273578","volume":"17","author":"G Zhu","year":"2021","unstructured":"Zhu G, Yang S, Wang R, Lei J, Ji P, Wang J et al (2021) P53\/miR-154 pathway regulates the epithelial-mesenchymal transition in glioblastoma multiforme cells by targeting TCF12. Neuropsychiatr Dis Treat 17:681\u2013693. https:\/\/doi.org\/10.2147\/NDT.S273578","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02831-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:58:21Z","timestamp":1732683501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02831-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2831"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02831-w","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in the absence of any commercial\/financial relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"74"}}